Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS-163 ETRAL Study

Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS-163 ETRAL Study. Lê, Minh Patrick; Valantin, Marc-Antoine; Assoumou, Lambert; Soulie, Cathia; Le Mestre, Soizic; Weiss, Laurence; Yazdanpanah, Yazdan; Molina, Jean-Michel; Bouchaud, Olivier; Raffi, François; Reynes, Jacques; Calvez, Vincent; Marcelin, Anne-Geneviève; Costagliola, Dominique; Katlama, Christine; Peytavin, Gilles; ANRS-163 ETRAL study group. Pharmacotherapy. 2019; 39: p.514-520. doi:10.1002/phar.2242
Article